<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of an Exclusive Patent License: Small Cell Lung Cancer Subtyping Using Plasma Cell-Free Nucleosomes</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of an Exclusive Patent License: Small Cell Lung Cancer Subtyping Using Plasma Cell-Free Nucleosomes</h1>
    <p class="timestamp">Published: 2023-01-20 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The National Cancer Institute (NCI), an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Yissum Research and Development ("Yissum"), the technology transfer company of the Hebrew University of Jerusalem, a non-profit research institution located in Jerusalem, Israel for NCI's rights to the patent applications listed in the Supplementary Information section of this notice.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2023-01019</p>
    <p><strong>Publication Date:</strong> 2023-01-20</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/01/20/2023-01019/prospective-grant-of-an-exclusive-patent-license-small-cell-lung-cancer-subtyping-using-plasma">https://www.federalregister.gov/documents/2023/01/20/2023-01019/prospective-grant-of-an-exclusive-patent-license-small-cell-lung-cancer-subtyping-using-plasma</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-01019</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
